Literature DB >> 1411651

The cardiotoxicity of chemotherapeutic drugs.

A Allen1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1411651

Source DB:  PubMed          Journal:  Semin Oncol        ISSN： 0093-7754            Impact factor:   4.929


× No keyword cloud information.
  32 in total

1.  Detection of doxorubicin cardiotoxicity by using iodine-123 BMIPP early dynamic SPECT: quantitative evaluation of early abnormality of fatty acid metabolism with the Rutland method.

Authors:  K Saito; K Takeda; S Okamoto; R Okamoto; K Makino; Y Tameda; Y Nomura; H Maeda; T Ichihara; T Nakano
Journal:  J Nucl Cardiol       Date:  2000 Nov-Dec       Impact factor: 5.952

2.  Pregnancy-associated cardiomyopathy in survivors of childhood cancer.

Authors:  Melissa R Hines; Daniel A Mulrooney; Melissa M Hudson; Kirsten K Ness; Daniel M Green; Scott C Howard; Matthew Krasin; Monika L Metzger
Journal:  J Cancer Surviv       Date:  2015-06-05       Impact factor: 4.442

3.  Pharmacogenomics meets precision cardio-oncology: is there synergistic potential?

Authors:  Jennifer K Hockings; Jessica A Castrillon; Feixiong Cheng
Journal:  Hum Mol Genet       Date:  2020-10-20       Impact factor: 6.150

Review 4.  Exercise Recommendations for the Management of Symptoms Clusters Resulting From Cancer and Cancer Treatments.

Authors:  Karen M Mustian; Calvin L Cole; Po Ju Lin; Matt Asare; Chunkit Fung; Michelle C Janelsins; Charles S Kamen; Luke J Peppone; Allison Magnuson
Journal:  Semin Oncol Nurs       Date:  2016-10-21       Impact factor: 2.315

Review 5.  Systems biology approaches to adverse drug effects: the example of cardio-oncology.

Authors:  Sherry-Ann Brown; Nicole Sandhu; Joerg Herrmann
Journal:  Nat Rev Clin Oncol       Date:  2015-10-13       Impact factor: 66.675

Review 6.  Clinical and preclinical modulation of chemotherapy-induced toxicity in patients with cancer.

Authors:  K Hoekman; W J van der Vijgh; J B Vermorken
Journal:  Drugs       Date:  1999-02       Impact factor: 9.546

7.  The G671V variant of MRP1/ABCC1 links doxorubicin-induced acute cardiac toxicity to disposition of the glutathione conjugate of 4-hydroxy-2-trans-nonenal.

Authors:  Paiboon Jungsuwadee; Tianyong Zhao; Elzbieta I Stolarczyk; Christian M Paumi; D Allan Butterfield; Daret K St Clair; Mary Vore
Journal:  Pharmacogenet Genomics       Date:  2012-04       Impact factor: 2.089

8.  Career readiness in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study.

Authors:  David Strauser; James L Klosky; Tara M Brinkman; Alex W K Wong; Fong Chan; Jennifer Lanctot; Rohit P Ojha; Leslie L Robison; Melissa M Hudson; Kirsten K Ness
Journal:  J Cancer Surviv       Date:  2014-07-22       Impact factor: 4.442

9.  Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia - From the St. Jude Lifetime Cohort.

Authors:  Kerri A Nottage; Kirsten K Ness; Chenghong Li; Deokumar Srivastava; Leslie L Robison; Melissa M Hudson
Journal:  Br J Haematol       Date:  2014-01-27       Impact factor: 6.998

10.  Phase I trial of mitoxantrone and granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced solid malignancies.

Authors:  J H Schiller; B Storer; R Arzoomanian; K Tutsch; D Alberti; D Spriggs
Journal:  Invest New Drugs       Date:  1993-11       Impact factor: 3.850
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.